425 related articles for article (PubMed ID: 20093851)
1. Antigen-specific immunotherapy against allergic rhinitis: the state of the art.
Fujimura T; Okamoto Y
Allergol Int; 2010 Mar; 59(1):21-31. PubMed ID: 20093851
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
[TBL] [Abstract][Full Text] [Related]
3. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
[TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy for Japanese cedar pollinosis.
Okubo K; Gotoh M
Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
[TBL] [Abstract][Full Text] [Related]
5. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens.
Hirahara K; Tatsuta T; Takatori T; Ohtsuki M; Kirinaka H; Kawaguchi J; Serizawa N; Taniguchi Y; Saito S; Sakaguchi M; Inouye S; Shiraishi A
J Allergy Clin Immunol; 2001 Jul; 108(1):94-100. PubMed ID: 11447388
[TBL] [Abstract][Full Text] [Related]
7. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination.
Ito Y; Takahashi Y; Fujita T; Fukuyama S
Auris Nasus Larynx; 1997 Apr; 24(2):163-70. PubMed ID: 9134139
[TBL] [Abstract][Full Text] [Related]
8. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract.
Kawakami A; Koketsu R; Suzukawa M; Nagao M; Hiraguchi Y; Tokuda R; Fujisawa T; Nagase H; Ohta K; Yamamoto K; Yamaguchi M
Int Arch Allergy Immunol; 2008; 146 Suppl 1():54-60. PubMed ID: 18504408
[TBL] [Abstract][Full Text] [Related]
9. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
Yuta A; Miyamoto Y; Ogihara H; Hattori R; Okubo K
Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
[TBL] [Abstract][Full Text] [Related]
10. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
11. Approaches to immunotherapies for Japanese cedar pollinosis.
Sakaguchi M; Hirahara K; Fujimura T; Toda M
Auris Nasus Larynx; 2011 Aug; 38(4):431-8. PubMed ID: 21227607
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
Ariano R; Panzani RC; Mistrello G
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
Valovirta E; Jacobsen L; Ljørring C; Koivikko A; Savolainen J
Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565
[TBL] [Abstract][Full Text] [Related]
14. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
15. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
Nichani JR; de Carpentier J
J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
Smith H; White P; Annila I; Poole J; Andre C; Frew A
J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
[TBL] [Abstract][Full Text] [Related]
17. Peptide immunotherapy for allergic diseases using a rice-based edible vaccine.
Hiroi T; Takaiwa F
Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):455-60. PubMed ID: 17088651
[TBL] [Abstract][Full Text] [Related]
18. Frequency of sensitization to different pollen groups and results of specific immunotherapy.
Martín-Gil D; Neffen H; Oehling A
Allergol Immunopathol (Madr); 1978; 6(4):325-32. PubMed ID: 735982
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
Okamoto Y; Okubo K; Yonekura S; Hashiguchi K; Goto M; Otsuka T; Murata T; Nakao Y; Kanazawa C; Nagakura H; Okawa T; Nakano K; Hisamitsu M; Kaneko S; Konno A
Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909
[TBL] [Abstract][Full Text] [Related]
20. [The evaluation of hyposensitization with sugi pollen extracts in patients with nasal allergy to Japanese sugi pollen].
Ukai K; Amesara R; Masuda S; Nakamato S; Ohkawa C; Okamoto K; Sakakura Y
Arerugi; 1994 Feb; 43(2 Pt 1):101-5. PubMed ID: 8147711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
